19.06.2020 14:28:21

Perrigo To Divest U.K-based Generic Prescription Pharmaceuticals Business - Quick Facts

(RTTNews) - Perrigo Co. plc (PRGO) announced Friday that it has reached a definitive agreement to sell its U.K.-based non-core generic prescription pharmaceuticals business to a U.K.-headquartered private equity firm for 156 million British pounds or about $195 million in cash.

This transaction, which was signed and closed on the same day, represents another step in Perrigo's transformation to a consumer-focused self-care company.

Perrigo's U.K.-based Rosemont Pharmaceuticals is a generic prescription pharmaceuticals manufacturer focused on liquid medicines.

Analysen zu Perrigo Company PLCmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Perrigo Company PLC 23,99 -0,29% Perrigo Company PLC